(Q46099535)

19 December 2017

title

The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial (English)

1 reference

19 December 2017

7

Ralph H B Benedict

1 reference

19 December 2017

author name string

Sarah A Morrow

1

1 reference

19 December 2017

Tanya Kaushik

2

1 reference

19 December 2017

Peter Zarevics

3

1 reference

19 December 2017

David Erlanger

4

1 reference

19 December 2017

Mark F Bear

5

1 reference

19 December 2017

Frederick E Munschauer

6

1 reference

19 December 2017

publication date

5 March 2009

1 reference

19 December 2017

published in

Journal of Neurology

1 reference

19 December 2017

volume

256

1 reference

19 December 2017

issue

7

1 reference

19 December 2017

page(s)

1095-1102

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s00415-009-5074-x

exact match

0 references

cites work

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5074-X

Donepezil improved memory in multiple sclerosis in a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5074-X

Minimal neuropsychological assessment of MS patients: a consensus approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5074-X

The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5074-X

Effects of single-dose methylphenidate on cognitive performance in patients with traumatic brain injury: a double-blind placebo-controlled study

21 January 2018

1 reference

12 December 2020

Brain dopamine and reward

1 reference

12 December 2020

Clinical global impressions in Alzheimer's clinical trials.

1 reference

12 December 2020

Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.

1 reference

12 December 2020

Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial

1 reference

12 December 2020

Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex

1 reference

12 December 2020

What can research on schizophrenia tell us about the cognitive neuroscience of working memory?

1 reference

12 December 2020

D-amphetamine facilitation of morris water task performance is blocked by eticlopride and correlated with increased dopamine synthesis in the prefrontal cortex.

1 reference

12 December 2020

Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group.

1 reference

12 December 2020

Learning impairments in monkeys with combined but not separate excitotoxic lesions of the anterior and mediodorsal thalamic nuclei.

1 reference

12 December 2020

Effects of dextroamphetamine on cognitive performance and cortical activation.

1 reference

12 December 2020

How do memories leave their mark?

1 reference

12 December 2020

Methylphenidate improves visual-spatial memory in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder

1 reference

12 December 2020

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

12 December 2020

Cognitive dysfunction in multiple sclerosis: a review of recent developments

1 reference

12 December 2020

The levo enantiomer of amphetamine increases memory consolidation and gene expression in the hippocampus without producing locomotor stimulation

1 reference

12 December 2020

Effects of rivastigmine on memory and cognition in multiple sclerosis.

1 reference

12 December 2020

Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers

1 reference

12 December 2020

Beta1 adrenergic receptor-mediated enhancement of hippocampal CA3 network activity

1 reference

12 December 2020

Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures

1 reference

12 December 2020

Effects of using same- versus alternate-form memory tests during short-interval repeated assessments in multiple sclerosis.

1 reference

12 December 2020

Neuropsychology of multiple sclerosis

1 reference

12 December 2020

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

12 December 2020

Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine.

1 reference

12 December 2020

Disconnecting hippocampal projections to the anterior thalamus produces deficits on tests of spatial memory in rats.

1 reference

12 December 2020

A distinct role for norepinephrine in memory retrieval

1 reference

12 December 2020

Effects of methylphenidate on working memory in pigeons

1 reference

12 December 2020

Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine

1 reference

12 December 2020

Fornix-dependent induction of hippocampal CCAAT enhancer-binding protein [beta] and [delta] Co-localizes with phosphorylated cAMP response element-binding protein and accompanies long-term memory consolidation.

1 reference

12 December 2020

The neurochemistry and pharmacology of extinction behavior

1 reference

12 December 2020

Actions of norepinephrine in the rat hippocampus

1 reference

12 December 2020

Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients

1 reference

12 December 2020

Amphetamine enhances memory retention and facilitates norepinephrine release from the hippocampus in rats

1 reference

12 December 2020

Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).

1 reference

12 December 2020

Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients

1 reference

12 December 2020

The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force

1 reference

12 December 2020

10.1007/S00415-009-5074-X

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

19263186

1 reference

19 December 2017